- Lobbying
- Lobbying by Rodan & Fields, LLC
Lobbying Relationship
Bills mentioned
S.2315: Over-the-Counter Drug Safety, Innovation, and Reform Act
Sponsor: Johnny Isakson (R-Ga.)
H.R.5333: Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Sponsor: Robert E. Latta (R-Ohio)
H.R.269: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Sponsor: Anna G. Eshoo (D-Calif.)
S.2740: Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
Sponsor: Johnny Isakson (R-Ga.)
H.R.748: CARES Act
Sponsor: Joe Courtney (D-Conn.)
H.R.5279: Cosmetic Safety Enhancement Act of 2019
Sponsor: Frank Pallone (D-N.J.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Albert Wynn | U.S. Congressman (92-08) |
Charles F. Bass | U.S. Congressman (97 - 07) & (11 - 13) |
Tim Hutchinson | U.S. Senator (97-03); U.S. Congressman (93-97) |
Jonathan Becker | Chief of Staff, Senator Amy Klobuchar (2010-13); Chief Counsel, Senator Amy Klobuchar (2007-09). |
Nancy E. Taylor | n/a |
Monica Schulteis | n/a |
Diane Blagman | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate